SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001739410-23-000014
Filing Date
2023-11-09
Accepted
2023-11-09 16:10:24
Documents
54
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rlyb-20230930.htm   iXBRL 10-Q 1197071
2 EX-31.1 rlyb-20230930xex311.htm EX-31.1 10289
3 EX-31.2 rlyb-20230930xex312.htm EX-31.2 10278
4 EX-32.1 rlyb-20230930xex321.htm EX-32.1 4852
5 EX-32.2 rlyb-20230930xex322.htm EX-32.2 4834
11 rlyb-20230930_g1.jpg GRAPHIC 8945
  Complete submission text file 0001739410-23-000014.txt   4469590

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rlyb-20230930.xsd EX-101.SCH 25269
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rlyb-20230930_cal.xml EX-101.CAL 44034
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rlyb-20230930_def.xml EX-101.DEF 120705
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rlyb-20230930_lab.xml EX-101.LAB 389378
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rlyb-20230930_pre.xml EX-101.PRE 255999
48 EXTRACTED XBRL INSTANCE DOCUMENT rlyb-20230930_htm.xml XML 439795
Mailing Address 234 CHURCH STREET SUITE 1020 NEW HAVEN CT 06510
Business Address 234 CHURCH STREET SUITE 1020 NEW HAVEN CT 06510 203- 859-3820
Rallybio Corp (Filer) CIK: 0001739410 (see all company filings)

IRS No.: 851083789 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40693 | Film No.: 231392467
SIC: 2834 Pharmaceutical Preparations